Long-Term, Observational, Global Registry of Patients With Generalized Myasthenia Gravis Who Have Received Treatment With Complement C5 Inhibition Therapies

Study type

• Study topic:
  Human medicinal product
• Study type:
  Non-interventional study
• Scope of the study:
  Disease epidemiology

  Drug utilisation

  Effectiveness study (incl. comparative)

  Evaluation of patient-reported outcomes

  Hypothesis generation (including signal detection)

  Safety study (incl. comparative)
• Data collection methods:
  Primary data collection

Non-interventional study

• Non-interventional study design:
  Other
• Non-interventional study design, other:
  Longitudinal observational registry

Study drug and medical condition

• Medicinal product name:
  SOLIRIS
• Study drug International non-proprietary name (INN) or common name:
  ECULIZUMAB
• Anatomical Therapeutic Chemical (ATC) code:
  (L04AJ01) eculizumab

  eculizumab